North China Pharmaceutical, Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares North China Pharmaceutical, Limited with three other
companies in this sector in China:
Sichuan Kelun Pharmaceutical Company Limited
sales of 7.76 billion Chinese Renmimbi [US$1.14 billion]
of which 98%
was Medical and Pharmaceutical Products),
Joincare Pharmaceutical Group Industry Company Limited
(8.64 billion Chinese Renmimbi [US$1.26 billion]
of which 39%
was Chemical Agents), and
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
(7.90 billion Chinese Renmimbi [US$1.15 billion]
of which 95%
During the year ended December of 2015, sales at
North China Pharmaceutical, Limited were 7.90 billion Chinese Renmimbi (US$1.15 billion).
decrease of 16.0%
versus 2014, when the company's sales were 9.40 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 4.4% decline
in Medicine and Other Logistics Trade, from 2.10 billion Chinese Renmimbi to 2.01 billion Chinese Renmimbi.
There were also decreases in sales in
Other (down 1.0% to 106.95 million Chinese Renmimbi)